Dow Jones Rises on Tech Rebound, but Inflation Data Looms
Markets Daniel Marsh

Dow Jones Rises on Tech Rebound, but Inflation Data Looms

The Dow Jones Industrial Average closed higher Tuesday, buoyed by a tech sector rebound and lower oil prices. Investors are now focused on upcoming inflation data and the Federal Reserve meeting.

INTC AVGO MU AXP NKE UAL DAL BAC
Wall Street Mixed as AI Rally Faces Key Inflation Test
Markets Daniel Marsh

Wall Street Mixed as AI Rally Faces Key Inflation Test

U.S. stocks traded mixed Tuesday as the Dow and S&P 500 posted modest gains while the Nasdaq dipped, with market focus on upcoming inflation data and AI sector strength.

NUVL GSK AAPL INTC AVGO MU ADSK UAL DAL PFE RHHBY
Smart Logistics Global Soars 159% Before Nasdaq Volatility Halt
Markets Daniel Marsh

Smart Logistics Global Soars 159% Before Nasdaq Volatility Halt

Smart Logistics Global surged 159% to $1.33 before a Nasdaq volatility pause, pushing the stock above the $1 minimum bid-price needed for compliance.

SLGB
Reddit Stock Jumps as Analysts Flag Strong Ad Momentum
Markets Daniel Marsh

Reddit Stock Jumps as Analysts Flag Strong Ad Momentum

Reddit shares surged 6.6% after two analyst firms cited stronger ad demand and raised revenue forecasts, with Cleveland Research noting 45% of advertisers beat ROI targets in Q2.

RDDT SNAP PINS META GOOGL
Autozi Stock Surges 400% After Reverse Split, But Going Concern Warning Looms
Markets Daniel Marsh

Autozi Stock Surges 400% After Reverse Split, But Going Concern Warning Looms

Autozi shares jumped over 400% to $5.69 after a reverse split, but the company reported a 63% revenue decline and warned of substantial doubt about its ability to continue.

AZI
Redwire Stock Drops 6.5% on $500M ATM Offering Plan
Markets Daniel Marsh

Redwire Stock Drops 6.5% on $500M ATM Offering Plan

Redwire Corp shares fell 6.5% to $17.37 after filing a $500M at-the-market stock program, raising dilution concerns despite record backlog and strong revenue growth.

RDW RKLB ASTS PL
GSK's $10.6B Nuvalent Bid Drives Stock Near Offer Price
Markets Daniel Marsh

GSK's $10.6B Nuvalent Bid Drives Stock Near Offer Price

Nuvalent shares jumped 38.9% to $122.93 after GSK's $10.6 billion buyout offer, as investors bet on the deal closing with two lead lung-cancer drugs under FDA review.

NUVL GSK
Smucker Shares Rise on Earnings Beat Despite Sales Warning
Earnings James Calloway

Smucker Shares Rise on Earnings Beat Despite Sales Warning

J.M. Smucker shares jumped 3.16% premarket after beating Q4 profit estimates and guiding fiscal 2027 adjusted earnings above Wall Street forecasts, despite warning annual sales will fall.

SJM
Regentis Biomaterials Stock: Surgeon Training for GelrinC Knee Implant Set for Q3
Technology Sarah Chen

Regentis Biomaterials Stock: Surgeon Training for GelrinC Knee Implant Set for Q3

Regentis Biomaterials shares fell slightly premarket after announcing European surgeon training for its GelrinC knee implant will start in Q3, a commercial milestone but not yet revenue.

RGNT
IREN Shares Near $60 as AI Cloud Strategy Gains Traction
Technology Sarah Chen

IREN Shares Near $60 as AI Cloud Strategy Gains Traction

IREN shares jumped 8.9% to $59.19, boosted by bitcoin recovery and its AI cloud pivot. Premarket quotes hit $60.07.

IREN MARA RIOT CORZ NVDA MSFT
AT&T Shares Edge Up as $45B Payout Plan and 2026 Guidance Hold Steady
Markets Daniel Marsh

AT&T Shares Edge Up as $45B Payout Plan and 2026 Guidance Hold Steady

AT&T shares edged up pre-market after reaffirming 2026 targets and a $45B+ payout plan, providing a cash-flow marker as satellite broadband competition looms.

T TMUS VZ
GSK Acquires Nuvalent for $10.6B in Oncology Push Ahead of HIV Patent Cliff
Markets Daniel Marsh

GSK Acquires Nuvalent for $10.6B in Oncology Push Ahead of HIV Patent Cliff

GSK buys Nuvalent for $10.6B, paying a 40% premium, to strengthen its oncology portfolio and offset upcoming HIV drug patent losses.

GSK NUVL AZN